Literature DB >> 21831116

Antiretroviral treatment uptake and attrition among HIV-positive patients with tuberculosis in Kibera, Kenya.

K Tayler-Smith1, R Zachariah, M Manzi, W Kizito, A Vandenbulcke, J Sitienei, J Chakaya, A D Harries.   

Abstract

Using data of human immunodeficiency virus-positive patients with tuberculosis from three primary care clinics in Kibera slums, Nairobi, Kenya, we report on the proportion that started antiretroviral treatment (ART) and attrition (deaths, lost to follow-up and stopped treatment) before and while on ART. Of 427 ART eligible patients, enrolled between January 2004 and December 2008, 70% started ART, 19% were lost to attrition and 11% had not initiated ART. Of those who started ART, 14% were lost to attrition, making a cumulative pre-ART and ART attrition of 33%. ART uptake among patients with TB was relatively good, but programme attrition was high and needs urgent addressing.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21831116     DOI: 10.1111/j.1365-3156.2011.02863.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  8 in total

1.  A successful model for rapid triage of symptomatic patients at an HIV testing site in Haiti.

Authors:  Morgan C Esperance; Serena P Koenig; Colette Guiteau; Fabienne Homeus; Jessy Devieux; Jenny Edouard; Rachel Bertrand; Patrice Joseph; Clovy Bellot; Diessy Decome; Jean W Pape; Patrice Severe
Journal:  Int Health       Date:  2015-07-14       Impact factor: 2.473

2.  Timing of antiretroviral therapy and effects on tuberculosis treatment outcomes in HIV-co-infected patients in Malawi.

Authors:  H S Kanyerere; J Mpunga; H Tweya; M Edginton; A D Harries; S G Hinderaker; F Chimbwandira; A Gonani; K Mbendera
Journal:  Public Health Action       Date:  2012-10-30

3.  Retention in pre-antiretroviral treatment care in a district of Karnataka, India: how well are we doing?

Authors:  D Shankar; A M V Kumar; B Rewari; S Kumar; S Shastri; S Satyanarayana; R Ananthakrishnan; S B Nagaraja; M Devi; N Bhargava; M Das; R Zachariah
Journal:  Public Health Action       Date:  2014-12-21

4.  Timing of antiretroviral therapy in Cambodian hospital after diagnosis of tuberculosis: impact of revised WHO guidelines.

Authors:  Kimcheng Choun; Reaksmey Pe; Sopheak Thai; Natalie Lorent; Lutgarde Lynen; Johan van Griensven
Journal:  Bull World Health Organ       Date:  2012-12-12       Impact factor: 9.408

5.  Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011).

Authors:  Richard Kaplan; Judy Caldwell; Keren Middelkoop; Linda-Gail Bekker; Robin Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-15       Impact factor: 3.731

6.  Assessment of national tuberculosis and HIV collaborative program implementation status in health care settings of Ethiopia.

Authors:  Wudinesh Belete; Minilik Demissie; Atsbeha Gebreegziabher; Desta Kassa; Gebremedine Gebre-Michael; Getnet Mesfin; Abebaw Kebede; Andargachew Kumsa; Lelissa Fekadu; Biruk Kebede; Fekadeselassie Mikru; Kassa Hailu; Addisalem Yilma; Eshetu Kebede; Ismael Hassen; Abera Bekele; Getachew Wondimagegne; Kumlachew Abate; Daniel Fiseha; Ezra Shimeles; Yibeltal Assefa
Journal:  Ethiop J Public Health Nutr       Date:  2017

7.  The pattern of attrition from an antiretroviral treatment program in Nigeria.

Authors:  Solomon Odafe; Kwasi Torpey; Hadiza Khamofu; Obinna Ogbanufe; Edward A Oladele; Oluwatosin Kuti; Oluwasanmi Adedokun; Titilope Badru; Emeka Okechukwu; Otto Chabikuli
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

8.  TB treatment outcomes among TB-HIV co-infections in Karnataka, India: how do these compare with non-HIV tuberculosis outcomes in the province?

Authors:  Suresh Shastri; Balaji Naik; Anita Shet; Bharat Rewari; Ayesha De Costa
Journal:  BMC Public Health       Date:  2013-09-11       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.